Pattern recognition of microcirculation with super-resolution ultrasound imaging provides markers for early tumor response to anti-angiogenic therapy

  • Theranostics. 2024 Jan 20;14(3):1312-1324. doi: 10.7150/thno.89306.
Jingyi Yin  1 Feihong Dong  2  3  4 Jian An  1 Tianyu Guo  2 Heping Cheng  2  3  4  5 Jiabin Zhang  2  3  4 Jue Zhang  1  4  5  6
Affiliations
  • 1. Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
  • 2. College of Future Technology, Peking University, Beijing, China.
  • 3. State Key Laboratory of Membrane Biology, Peking-Tsinghua Center for Life Sciences, and Institute of Molecular Medicine, Peking University, Beijing, China.
  • 4. National Biomedical Imaging Center, Peking University, Beijing, China.
  • 5. Research Unit of Mitochondria in Brain Diseases, Chinese Academy of Medical Sciences, PKU-Nanjing Institute of Translational Medicine, Nanjing, China.
  • 6. College of Engineering, Peking University, Beijing, China.
Abstract

Rationale: Cancer treatment outcome is traditionally evaluated by tumor volume change in clinics, while tumor microvascular heterogeneity reflecting tumor response has not been fully explored due to technical limitations. Methods: We introduce a new paradigm in super-resolution ultrasound imaging, termed pattern recognition of microcirculation (PARM), which identifies both hemodynamic and morphological patterns of tumor microcirculation hidden in spatio-temporal space trajectories of microbubbles. Results: PARM demonstrates the ability to distinguish different local blood flow velocities separated by a distance of 24 μm. Compared with traditional vascular parameters, PARM-derived heterogeneity parameters prove to be more sensitive to microvascular changes following anti-angiogenic therapy. Particularly, PARM-identified "sentinel" microvasculature, exhibiting evident structural changes as early as 24 hours after treatment initiation, correlates significantly with subsequent tumor volume changes (|r| > 0.9, P < 0.05). This provides prognostic insight into tumor response much earlier than clinical criteria. Conclusions: The ability of PARM to noninvasively quantify tumor vascular heterogeneity at the microvascular level may shed new light on early-stage assessment of Cancer therapy.

Keywords
Anti-angiogenic treatment; Pattern recognition; Super-resolution ultrasound imaging; Tumor heterogeneity; Tumor microvasculature.
Products